Initial results of Transcatheter modification of left atrial appendage by obliteration with device in patients with Nonvalvular atrial fibrillation: Real-world data from the TERMINATOR registry

CONCLUSIONS: These preliminary data demonstrated percutaneous LAAC with WATCHMAN device might have a potential to reduce stroke and bleeding events for patients with NVAF. Further investigation is mandatory to confirm the long-term results of this strategy using this transcatheter local therapy instead of life-long systemic anticoagulation.PMID:37802202 | DOI:10.1016/j.jjcc.2023.09.010

Source: Journal of Cardiology - October 6, 2023 Category: Cardiology Authors: Hidehiko Hara Shunsuke Kubo Yoshifumi Nakajima Takashi Matsumoto Yusuke Kondo Hiroki Sugane Kenji Okubo Koji Nakagawa Daisuke Nagatomo Daisuke Hachinohe Shigeki Kusa Masahiko Goya Mamoru Nanasato Takeshi Arita Hiro Yamasaki Kensuke Kuwabara Tomotaka Yoshi Source Type: research